Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precancerous Conditions 4Neoplasms 2Adenomatous Polyposis Coli 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pain 1Leukoplakia, Oral 1Inflammation 1Hypertension 1Desmoid Tumors 1Coproporphyria 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

relacorilant 3Nutrition Assessment 2ganirelix 1clevidipine 1cediranib 1benazepril 1aliskiren 1Vitamin D 1Therapeutics 1Surveys and Questionnaires 1Sulindac 1Resistance Training 1Ramipril 1Observation 1Methyltestosterone 1Methods 1Losartan 1Lisinopril 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Interviews as Topic 1Fatty Acids, Omega-3 1Enalapril 1Educational Status 1Desvenlafaxine Succinate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hypertension × Sulindac × Clear all
NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡